Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.

MLA

Martini, Dylan J., et al. “Adiposity May Predict Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy in Phase 1 Clinical Trials.” Cancer (0008543X), vol. 126, no. 3, Feb. 2020, pp. 575–82. EBSCOhost, https://doi.org/10.1002/cncr.32576.

APA

Martini, D. J., Kline, M. R., Liu, Y., Shabto, J. M., Williams, M. A., Khan, A. I., Lewis, C., Collins, H., Akce, M., Kissick, H. T., Carthon, B. C., Shaib, W. L., Alese, O. B., Pillai, R. N., Steuer, C. E., Wu, C. S., Lawson, D. H., Kudchadkar, R. R., El, R. B. F., & Ramalingam, S. S. (2020). Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials. Cancer (0008543X), 126(3), 575–582. https://doi.org/10.1002/cncr.32576

Chicago

Martini, Dylan J., Meredith R. Kline, Yuan Liu, Julie M. Shabto, Milton A. Williams, Amir Ishaq Khan, Colleen Lewis, et al. 2020. “Adiposity May Predict Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy in Phase 1 Clinical Trials.” Cancer (0008543X) 126 (3): 575–82. doi:10.1002/cncr.32576.